Monthly plans ship freeRead the terms

ScienceHow kanna compares

A table, not a verdict.

Kanna beside coffee, alcohol, CBD and kava, on the same six questions. Every figure cites its source, and a cell with no figure says so. No cell is scored and no column wins.

Kanna and coffee, on six questions, every figure with its source
KannaCoffee (caffeine)
What it isA South African succulent herb; its extracts are sold in the US as dietary supplement ingredients.12Caffeine, a bitter substance that occurs in more than 60 plants, including coffee beans and tea leaves.3
US legal statusNot listed in the federal controlled-substance schedules (21 CFR 1308.11 to 1308.15, checked against the eCFR of 2026-11-18).4 State rules are not covered here.Legal; not listed in the federal controlled-substance schedules (21 CFR 1308.11 to 1308.15).4
OnsetNo published source gives a typical onset. Two placebo-controlled studies took their measures 2 hours after a 25 mg dose: one of Zembrin in 16 healthy adults, one of an unnamed extract given for 8 days to 60 trained adults.56Reaches its peak level in the blood within one hour.3
DurationNo published figure.Effects can be felt for four to six hours.3
How it actsIn laboratory assays, Zembrin, a branded kanna extract, blocked the serotonin transporter and inhibited the enzyme PDE4.*7 Not shown for our product.8Stimulates the central nervous system, which can make you feel more awake.3
What research reportsFew studies, all small and short, mostly of one branded extract, Zembrin, in healthy adults: lower amygdala reactivity, better scores on some thinking tests, good tolerance.*5910 None ran longer than 3 months, and none tested a THRYVE gummy.118 Kanna's cautions are in the safety note under this table.The FDA cites 400 mg a day, about two to three 12-ounce cups of coffee, as an amount not generally associated with negative effects.12 Stopping regular use suddenly can bring withdrawal, such as headaches and drowsiness.3

Before your first morning

ADULTS 21+

WARNING: Effects vary by individual.

Do not use if you take an SSRI, SNRI, MAOI, tricyclic antidepressant, triptan, or any other medication that affects serotonin.

Consult a physician before use if you take any prescription medication, have a medical condition, or are pregnant or nursing.

Keep out of reach of children.

A review published in 2021 found no reports to date of severe adverse reactions or herb-drug interactions, and still advises caution with medication of the kind the second warning line names; it also flags medicines that act on the enzyme PDE4.1

The pouch says nothing about taking THRYVE with coffee, alcohol, CBD or kava, and we do not fill that silence here.

* Marks a statement about what kanna or its alkaloids did in published research, or how a historical writer described it. None of it is a claim about this product.

[?]These statements made have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

References

Numbered in the order each source is first cited on this page. Titles are printed as their publishers printed them.

  1. Brendler T, Brinckmann JA, Feiter U, Gericke N, Lang L, Pozharitskaya ON, Shikov AN, Smith M, Van Wyk BE (2021). Sceletium for Managing Anxiety, Depression and Cognitive Impairment: A Traditional Herbal Medicine in Modern-Day Regulatory Systems. Current Neuropharmacology 19(9):1384-1400. doi:10.2174/1570159X19666210215124737 Back to the text
  2. Murbach TS, Hirka G, Szakonyiné IP, Gericke N, Endres JR (2014). A toxicological safety assessment of a standardized extract of Sceletium tortuosum (Zembrin®) in rats. Food and Chemical Toxicology 74:190-199. doi:10.1016/j.fct.2014.09.017 Back to the text
  3. MedlinePlus, U.S. National Library of Medicine. Caffeine. MedlinePlus (NIH). medlineplus.gov/caffeine.html Back to the text
  4. Drug Enforcement Administration (U.S. Department of Justice) (2026). 21 CFR Part 1308 - Schedules of Controlled Substances, §§1308.11-1308.15 (Schedules I-V). Electronic Code of Federal Regulations (eCFR), up to date as of 2026-11-18 21 CFR 1308.11-1308.15. www.ecfr.gov/current/title-21/chapter-II/part-1308 Back to the text
  5. Terburg D, Syal S, Rosenberger LA, Heany S, Phillips N, Gericke N, Stein DJ, van Honk J (2013). Acute effects of Sceletium tortuosum (Zembrin), a dual 5-HT reuptake and PDE4 inhibitor, in the human amygdala and its connection to the hypothalamus. Neuropsychopharmacology 38(13):2708-2716. doi:10.1038/npp.2013.183 Back to the text
  6. Hoffman JR, Markus I, Dubnov-Raz G, Gepner Y (2020). Ergogenic Effects of 8 Days of Sceletium Tortuosum Supplementation on Mood, Visual Tracking, and Reaction in Recreationally Trained Men and Women. Journal of Strength and Conditioning Research 34(9):2476-2481. doi:10.1519/JSC.0000000000003693 Back to the text
  7. Harvey AL, Young LC, Viljoen AM, Gericke NP (2011). Pharmacological actions of the South African medicinal and functional food plant Sceletium tortuosum and its principal alkaloids. Journal of Ethnopharmacology 137(3):1124-1129. doi:10.1016/j.jep.2011.07.035 Back to the text
  8. THRYVE (client) (2026). THRYVE kanna gummies pouch: front, Supplement Facts, directions, warning. Back to the text
  9. Chiu S, Gericke N, Farina-Woodbury M, Badmaev V, Raheb H, Terpstra K, Antongiorgi J, Bureau Y, Cernovsky Z, Hou J, Sanchez V, Williams M, Copen J, Husni M, Goble L (2014). Proof-of-Concept Randomized Controlled Study of Cognition Effects of the Proprietary Extract Sceletium tortuosum (Zembrin) Targeting Phosphodiesterase-4 in Cognitively Healthy Subjects: Implications for Alzheimer's Dementia. Evidence-Based Complementary and Alternative Medicine 2014:682014. doi:10.1155/2014/682014 Back to the text
  10. Nell H, Siebert M, Chellan P, Gericke N (2013). A randomized, double-blind, parallel-group, placebo-controlled trial of Extract Sceletium tortuosum (Zembrin) in healthy adults. Journal of Alternative and Complementary Medicine 19(11):898-904. doi:10.1089/acm.2012.0185 Back to the text
  11. Olatunji TL, Siebert F, Adetunji AE, Harvey BH, Gericke J, Hamman JH, Van der Kooy F (2022). Sceletium tortuosum: A review on its phytochemistry, pharmacokinetics, biological, pre-clinical and clinical activities. Journal of Ethnopharmacology 287:114711. doi:10.1016/j.jep.2021.114711 Back to the text
  12. U.S. Food and Drug Administration. Spilling the Beans: How Much Caffeine is Too Much?. FDA Consumer Updates. www.fda.gov/consumers/consumer-updates/spilling-beans-how-much-caffeine-too-much Back to the text
  13. National Institute on Alcohol Abuse and Alcoholism (NIH). What Is A Standard Drink?. NIAAA. www.niaaa.nih.gov/alcohols-effects-health/what-standard-drink Back to the text
  14. United States Congress (2015). 23 U.S.C. 158 - National minimum drinking age. U.S. Government Publishing Office (govinfo), United States Code, 2015 edition Title 23, Chapter 1, §158. www.govinfo.gov/content/pkg/USCODE-2015-title23/html/USCODE-2015-title23-chap1-sec158.htm Back to the text
  15. National Institute on Alcohol Abuse and Alcoholism (NIH). The Basics: Defining How Much Alcohol is Too Much (Core Resource on Alcohol). NIAAA. www.niaaa.nih.gov/health-professionals-communities/core-resource-on-alcohol/basics-defining-how-much-alcohol-too-much Back to the text
  16. National Institute on Alcohol Abuse and Alcoholism (NIH). Alcohol's Effects on the Body. NIAAA. www.niaaa.nih.gov/alcohols-effects-health/alcohols-effects-body Back to the text
  17. National Institute on Alcohol Abuse and Alcoholism (NIH). Understanding the Dangers of Alcohol Overdose. NIAAA. www.niaaa.nih.gov/publications/brochures-and-fact-sheets/understanding-dangers-of-alcohol-overdose Back to the text
  18. National Institute on Drug Abuse (NIH) (2024). Cannabis (Marijuana) DrugFacts. NIDA. nida.nih.gov/publications/drugfacts/cannabis-marijuana Back to the text
  19. U.S. Food and Drug Administration. What You Need to Know (And What We're Working to Find Out) About Products Containing Cannabis or Cannabis-derived Compounds, Including CBD. FDA Consumer Updates. www.fda.gov/consumers/consumer-updates/what-you-need-know-and-what-were-working-find-out-about-products-containing-cannabis-or-cannabis Back to the text
  20. National Center for Complementary and Integrative Health (NIH). Cannabis (Marijuana) and Cannabinoids: What You Need To Know. NCCIH. www.nccih.nih.gov/health/cannabis-marijuana-and-cannabinoids-what-you-need-to-know Back to the text
  21. National Center for Complementary and Integrative Health (NIH). Kava. NCCIH. www.nccih.nih.gov/health/kava Back to the text